Apolinário, Alexsandra Conceição 
; Salata, Giovanna Cassone ; Souza, Marcelo Medina de; Chorilli, Marlus ; Lopes, Luciana Biagini
Fonte: AAPS PharmSciTech. Unidade: ICB
Assuntos: FARMACOLOGIA, GEL (FORMAS FARMACÊUTICAS), MEDICAMENTO, NANOTECNOLOGIA, QUIMIOTERÁPICOS, ANTINEOPLÁSICOS, NEOPLASIAS MAMÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
APOLINÁRIO, Alexsandra Conceição et al. Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a Nanoethosomal-Based Hydrogel for topical administration of Fenretinide. AAPS PharmSciTech, v. 23, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.1208/s12249-022-02257-1. Acesso em: 01 nov. 2024.APA
Apolinário, A. C., Salata, G. C., Souza, M. M. de, Chorilli, M., & Lopes, L. B. (2022). Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a Nanoethosomal-Based Hydrogel for topical administration of Fenretinide. AAPS PharmSciTech, 23, 1-14. doi:10.1208/s12249-022-02257-1NLM
Apolinário AC, Salata GC, Souza MM de, Chorilli M, Lopes LB. Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a Nanoethosomal-Based Hydrogel for topical administration of Fenretinide [Internet]. AAPS PharmSciTech. 2022 ; 23 1-14.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1208/s12249-022-02257-1Vancouver
Apolinário AC, Salata GC, Souza MM de, Chorilli M, Lopes LB. Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a Nanoethosomal-Based Hydrogel for topical administration of Fenretinide [Internet]. AAPS PharmSciTech. 2022 ; 23 1-14.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1208/s12249-022-02257-1
